Well Done LLC’s Elevance Health ELV Stock Holding History

Well Done LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3	Closed	-$1K	–	292
2018 Q4	$1K	Buy	+3	New	+$825	﹤0.01%	690

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Well Done LLC's ELV Position: Q1 2019 in Review

Well Done LLC sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 3 shares — an estimated $1K sold.

Well Done LLC first reported a position in ELV in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

Well Done LLC reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 3 Elevance Health shares in Q1 2019, an estimated $1K.
Well Done LLC first reported a position in Elevance Health in Q4 2018 and held it in 1 quarter.
Well Done LLC's Elevance Health position peaked at $1K in Q4 2018.
1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.